DNA Sequencing Market Size, Growth, Demands Outlook and Forecasts to 2030

According to the research report, the global DNA sequencing market size is expected to touch USD 40.64 Billion by 2030, from USD 8.41 Billion in 2020, growing with a significant CAGR of 17.5% from2021 to 2030.

The DNA sequencing market report offers a comprehensive study of the current state expected at the major drivers, market strategies, and key vendors’ growth. The report presents energetic visions to conclude and study the market size, market hopes, and competitive surroundings. The research also focuses on the important achievements of the market, research & development, and regional growth of the leading competitors operating in the market. The current trends of the global DNA sequencing market in conjunction with the geographical landscape of this vertical have also been included in this report.

The report offers intricate dynamics about different aspects of the global DNA sequencing market, which aids companies operating in the market in making strategic development decisions. The study also elaborates on significant changes that are highly anticipated to configure growth of the global DNA sequencing market during the forecast period. It also includes a key indicator assessment that highlights growth prospects of this market and estimates statistics related to growth of the market in terms of value (US$ Mn) and volume (tons).

Sample Link @ https://www.precedenceresearch.com/sample/1189

Report Scope of the DNA Sequencing Market

Report Highlights	Details
Market Size	US$ 40.64 billion by 2030
Growth Rate	CAGR of 17.5% from 2021 to 2030
Largest Market	North America
Fastest Growing Market	Asia Pacific
Base Year	2021
Forecast Period	2021 to 2030
Segments Covered	Product, technology, Application, End Use

This study covers a detailed segmentation of the global DNA sequencing market, along with key information and a competition outlook. The report mentions company profiles of players that are currently dominating the global DNA sequencing market, wherein various developments, expansions, and winning strategies practiced and implemented by leading players have been presented in detail.

Key Players

Agilent Technologies
Illumina, Inc.
QIAGEN
Perkin Elmer
Thermo Fisher Scientific
Hoffmann-La Roche Ltd.
Macrogen, Inc.
Bio-Rad Laboratories, Inc.
Oxford Nanopore Technologies Ltd.
Myriad Genetics

Market Segmentation

By Product

Instruments
Consumables
Services

By Technology

Third Generation DNA Sequencing
Next-Generation Sequencing
Sanger Sequencing

By Application

Clinical Investigation
Oncology
Forensics & Agrigenomics
Reproductive Health
HLA Typing
Others

By End-Use

Clinical Research
Academic Research
Biotechnology & Pharmaceutical Companies
Hospitals & Clinics
Others

By Geography

North America

U.S.
Canada

Europe

Germany
France
United Kingdom
Rest of Europe

Asia Pacific

China
Japan
India
Southeast Asia
Rest of Asia Pacific

Latin America

Brazil
Rest of Latin America

Middle East & Africa (MEA)

GCC
North Africa
South Africa
Rest of Middle East & Africa

Research Methodology

The research methodology adopted by analysts for compiling the global DNA sequencing market report is based on detailed primary as well as secondary research. With the help of in-depth insights of the market-affiliated information that is obtained and legitimated by market-admissible resources, analysts have offered riveting observations and authentic forecasts for the global market.

During the primary research phase, analysts interviewed market stakeholders, investors, brand managers, vice presidents, and sales and marketing managers. Based on data obtained through interviews of genuine resources, analysts have emphasized the changing scenario of the global market.

For secondary research, analysts scrutinized numerous annual report publications, white papers, market association publications, and company websites to obtain the necessary understanding of the global DNA sequencing market.

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective
1.2. Scope of the Study
1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach
2.2. Data Sources
2.3. Assumptions& Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. DNA Sequencing Market Variables and Scope

4.1. Introduction
4.2. Market Classification and Scope

Chapter 5. COVID 19 Impact on DNA Sequencing Market

5.1. Covid-19: DNA Sequencing Industry Impact
5.2. DNA Sequencing Business Impact Assessment: Covid-19
5.2.1. Services Challenges/Disruption
5.2.2. Market Trends and DNA Sequencing Opportunities in the COVID-19 Landscape for Major Markets
5.3. Strategic Measures against Covid-19
5.3.1. Government Support and Initiative to Combat Covid-19
5.3.2. Proposal for DNA Sequencing Market Players to deal with Covid-19 Pandemic Scenario

Chapter 6. DNA Sequencing Market Dynamics Analysis and Trends

6.1. Market Dynamics
6.1.1. Market Drivers
6.1.1.1. Increasing prevalence of cancer
6.1.1.2. Technological advances in next-generation sequencing technologies
6.1.2. Market Restraints
6.1.2.1. Stringent regulations
6.1.3. Market Opportunities
6.1.3.1. Rising demand for precision medicine
6.1.3.2. Technological advancements

Chapter 7. Global DNA Sequencing Market: Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis
7.1.1.1. DNA Sequencing Market Revenue by Market Players (2016 -2019)
7.1.1.2. DNA Sequencing Market Revenue Market Share by Market Players (2016 -2019)
7.1.2. Key Organic/Inorganic Strategies Adopted by Players
7.1.2.1. Product Portfolio Expansion, Geographic Expansion, Product Innovation
7.1.2.2. Merger and Acquisition, Collaboration and Partnerships
7.1.3. Market Players Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of End-users

Chapter 8. Global DNA Sequencing Market, By Product

8.1. DNA Sequencing Market, by Product, 2017 - 2030
8.1.1. Instruments
8.1.1.1. Market Revenue and Forecast (2017 - 2030)
8.1.2. Consumables
8.1.2.1. Market Revenue and Forecast (2017 - 2030)
8.1.3. Services
8.1.3.1. Market Revenue and Forecast (2017 - 2030)

Chapter 9. Global DNA Sequencing Market, By Technology

9.1. DNA Sequencing Market, by Technology, 2017 - 2030
9.1.1. Third Generation DNA Sequencing
9.1.1.1. Market Revenue and Forecast (2017 - 2030)
9.1.2. Next-Generation Sequencing
9.1.2.1. Market Revenue and Forecast (2017 - 2030)
9.1.3. Next-Generation Sequencing
9.1.3.1. Market Revenue and Forecast (2017 - 2030)

Chapter 10. Global DNA Sequencing Market, By Application

10.1. DNA Sequencing Market, by Application, 2017 - 2030
10.1.1. Clinical Investigation
10.1.1.1. Market Revenue and Forecast (2017 - 2030)
10.1.2. Oncology
10.1.2.1. Market Revenue and Forecast (2017 - 2030)
10.1.3. Forensics & Agrigenomics
10.1.3.1. Market Revenue and Forecast (2017 - 2030)
10.1.4. Reproductive Health
10.1.4.1. Market Revenue and Forecast (2017 - 2030)
10.1.5. HLA Typing
10.1.5.1. Market Revenue and Forecast (2017 - 2030)
10.1.6. Others
10.1.6.1. Market Revenue and Forecast (2017 - 2030)

Chapter 11. Global DNA Sequencing Market, By End Use

11.1. DNA Sequencing Market, by End-Use, 2017 - 2030
11.1.1. Clinical Research
11.1.1.1. Market Revenue and Forecast (2017 - 2030)
11.1.2. Academic Research
11.1.2.1. Market Revenue and Forecast (2017 - 2030)
11.1.3. Biotechnology & Pharmaceutical Companies
11.1.3.1. Market Revenue and Forecast (2017 - 2030)
11.1.4. Hospitals & Clinics
11.1.4.1. Market Revenue and Forecast (2017 - 2030)
11.1.5. Others
11.1.5.1. Market Revenue and Forecast (2017 - 2030)

Chapter 12. Global DNA Sequencing Market, Regional Estimates and Trend Forecast

12.1. North America
12.1.1. Market Revenue Forecast by Product(2017 - 2030)
12.1.2. Market Revenue Forecast by Technology(2017 - 2030)
12.1.3. Market Revenue Forecast by Application (2017 - 2030)
12.1.4. Market Revenue Forecast by End-Use (2017 - 2030)
12.1.5. U.S
12.1.5.1. Market Revenue Forecast (2017 - 2030)
12.1.6. Canada
12.1.6.1. Market Revenue Forecast (2017 - 2030)
12.2. Europe
12.2.1. Market Revenue Forecast by Product (2017 - 2030)
12.2.2. Market Revenue Forecast by Technology (2017 - 2030)
12.2.3. Market Revenue Forecast by Application (2017 - 2030)
12.2.4. Market Revenue Forecast by End-Use (2017 - 2030)
12.2.5. UK
12.2.5.1. Market Revenue Forecast (2017 - 2030)
12.2.6. Germany
12.2.6.1. Market Revenue Forecast (2017 - 2030)
12.2.7. France
12.2.7.1. Market Revenue Forecast (2017 - 2030)
12.2.8. Rest of EU
12.2.8.1. Market Revenue Forecast (2017 - 2030)
12.3. Asia Pacific (APAC)
12.3.1. Market Revenue Forecast by Product (2017 - 2030)
12.3.2. Market Revenue Forecast by Technology (2017 - 2030)
12.3.3. Market Revenue Forecast by Application (2017 - 2030)
12.3.4. Market Revenue Forecast by End-Use (2017 - 2030)
12.3.5. China
12.3.5.1. Market Revenue Forecast (2017 - 2030)
12.3.6. India
12.3.6.1. Market Revenue Forecast (2017 - 2030)
12.3.7. Japan
12.3.7.1. Market Revenue Forecast (2017 - 2030)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue Forecast (2017 - 2030)
12.4. LATAM
12.4.1. Market Revenue Forecast by Product (2017 - 2030)
12.4.2. Market Revenue Forecast by Technology (2017 - 2030)
12.4.3. Market Revenue Forecast by Application (2017 - 2030)
12.4.4. Market Revenue Forecast by End-Use (2017 - 2030)
12.4.5. Brazil
12.4.5.1. Market Revenue Forecast (2017 - 2030)
12.4.6. Rest of LATAM
12.4.6.1. Market Revenue Forecast (2017 - 2030)
12.5. Middle East and Africa (MEA)
12.5.1. Market Revenue Forecast by Product (2017 - 2030)
12.5.2. Market Revenue Forecast by Technology (2017 - 2030)
12.5.3. Market Revenue Forecast by Application (2017 - 2030)
12.5.4. Market Revenue Forecast by End-Use (2017 - 2030)
12.5.5. GCC
12.5.5.1. Market Revenue Forecast (2017 - 2030)
12.5.6. North Africa
12.5.6.1. Market Revenue Forecast (2017 - 2030)
12.5.7. South Africa
12.5.7.1. Market Revenue Forecast (2017 - 2030)
12.5.8. Rest of MEA
12.5.8.1. Market Revenue Forecast (2017 - 2030)

Chapter 13. Company Profiles

13.1. Agilent Technologies
13.1.1. Company Overview, Business Information, Regional Presence
13.1.2. Product Portfolio Analysis
13.1.2.1. Product Details, Specification, Application
13.1.3. Revenue, Price, and Gross Margin (2017 - 2020)
13.1.4. Recent Developments and Strategies
13.2. Illumina, Inc.
13.2.1. Company Overview, Business Information, Regional Presence
13.2.2. Product Portfolio Analysis
13.2.2.1. Product Details, Specification, Application
13.2.3. Revenue, Price, and Gross Margin (2017 - 2020)
13.2.4. Recent Developments and Strategies
13.3. QIAGEN
13.3.1. Company Overview, Business Information, Regional Presence
13.3.2. Product Portfolio Analysis
13.3.2.1. Product Details, Specification, Application
13.3.3. Revenue, Price, and Gross Margin (2017 - 2020)
13.3.4. Recent Developments and Strategies
13.4. Perkin Elmer
13.4.1. Company Overview, Business Information, Regional Presence
13.4.2. Product Portfolio Analysis
13.4.2.1. Product Details, Specification, Application
13.4.3. Revenue, Price, and Gross Margin (2017 - 2020)
13.4.4. Recent Developments and Strategies
13.5. Thermo Fisher Scientific
13.5.1. Company Overview, Business Information, Regional Presence
13.5.2. Product Portfolio Analysis
13.5.2.1. Product Details, Specification, Application
13.5.3. Revenue, Price, and Gross Margin (2017 - 2020)
13.5.4. Recent Developments and Strategies
13.6. F. Hoffmann-La Roche Ltd.
13.6.1. Company Overview, Business Information, Regional Presence
13.6.2. Product Portfolio Analysis
13.6.2.1. Product Details, Specification, Application
13.6.3. Revenue, Price, and Gross Margin (2017 - 2020)
13.6.4. Recent Developments and Strategies
13.7. Macrogen, Inc.
13.7.1. Company Overview, Business Information, Regional Presence
13.7.2. Product Portfolio Analysis
13.7.2.1. Product Details, Specification, Application
13.7.3. Revenue, Price, and Gross Margin (2017 - 2020)
13.7.4. Recent Developments and Strategies
13.8. Bio-Rad Laboratories, Inc.
13.8.1. Company Overview, Business Information, Regional Presence
13.8.2. Product Portfolio Analysis
13.8.2.1. Product Details, Specification, Application
13.8.3. Revenue, Price, and Gross Margin (2017 - 2020)
13.8.4. Recent Developments and Strategies
13.9. Oxford Nanopore Technologies Ltd.
13.9.1. Company Overview, Business Information, Regional Presence
13.9.2. Product Portfolio Analysis
13.9.2.1. Product Details, Specification, Application
13.9.3. Revenue, Price, and Gross Margin (2017 - 2020)
13.9.4. Recent Developments and Strategies
13.10. Myriad Genetics
13.10.1. Company Overview, Business Information, Regional Presence
13.10.2. Product Portfolio Analysis
13.10.2.1. Product Details, Specification, Application
13.10.3. Revenue, Price, and Gross Margin (2017 - 2020)
13.10.4. Recent Developments and Strategies